Titlebook: Drug Dosing in Obesity; Volume I: Antimicrob Syed Tabish R. Zaidi,Jason A. Roberts Book 2016 Springer International Publishing Switzerland

只看該作者 · 發(fā)表于 2025-3-28 19:02:39

Glycopeptides and Antibiotics for Gram-positive Bacterial Infections,ns caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides, lipopeptides, linezolid and quinupristin/dalfopristin in obesity. Specific dosing recom

只看該作者 · 發(fā)表于 2025-3-29 02:56:14

Azole Antifungal Agents,gement of systemic fungal infections. Their application in the prophylaxis against and treatment of systemic mycoses continues to evolve, with ongoing advancements in drug delivery, efficacy, monitoring and side effect profiling. Pharmacokinetic changes and dose guidance for these agents in the obes

只看該作者 · 發(fā)表于 2025-3-29 05:10:52

只看該作者 · 發(fā)表于 2025-3-29 09:27:52

只看該作者 · 發(fā)表于 2025-3-29 13:30:14

只看該作者 · 發(fā)表于 2025-3-29 15:35:02

Book 2016ng up-to-date information on antimicrobial dosing in obese patients. Doctors, pharmacists, nurses working in hospital settings, and students of health courses (medical, pharmacy and nursing students) will find this book particularly useful..

只看該作者 · 發(fā)表于 2025-3-29 20:09:40

只看該作者 · 發(fā)表于 2025-3-30 02:56:53

		自動登錄	找回密碼
密碼			To register

關于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 22:01
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權所有 All rights reserved